Aurobindo Pharma Ltd has announced regarding the USFDA inspection of Unit IV, a general injectable formulation manufacturing facility of the Company. The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from USFDA.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.500.2 as compared to the previous close of Rs. 493.35. The total number of shares traded during the day was 145779 in over 3274 trades.
The stock hit an intraday high of Rs. 502.8 and intraday low of 482.5. The net turnover during the day was Rs. 71654037.